Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

Oct 23, 2024  · BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …


Install CouponFollow Chrome Extension   CouponFollow Extension

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 23, 2024  · BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …

a9oncology.com

$175
OFF

Alpha-9 Becomes Latest Radiopharma To Secure Funds With $175m …

4 weeks from now

Oct 24, 2024  · This latest financing comes after a flood of investment into the radiopharma arena over the last few years. Earlier this month, Aktis Oncology raised $175m to support the …

pharmaceutical-technology.com

$175
OFF

Radiopharma Startup Alpha-9 Nets $175M Series C

4 weeks from now

Oct 24, 2024  · Credit: Love Employee/Getty Images. In the latest deal for the red-hot radiopharmaceutical field, Alpha-9 Oncology announced an oversubscribed $175 million series …

insideprecisionmedicine.com

$175
OFF

Alpha-9 Oncology Raises $175M In Series C Financing

4 weeks from now

Oct 25, 2024  · NEW YORK – Alpha-9 Oncology on Wednesday said it has raised $175 million in an oversubscribed Series C funding round, which it will use to advance its pipeline of targeted …

precisionmedicineonline.com

$175
OFF

Our Investment In Alpha-9 Oncology - Generalcatalyst.com

4 weeks from now

Oct 23, 2024  · Today, we are excited to announce our investment in Alpha-9 Oncology’s $175M Series C funding round. Radiopharmaceuticals have the potential to harness the power of …

generalcatalyst.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 24, 2024  · BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing …

biospace.com

$175
OFF

Alpha-9 Oncology Secures $175M Series C To Drive …

4 weeks from now

Boston, MA and Vancouver, Canada, October 23, 2024 (PRNewswire) -- Alpha-9 Oncology has raised $175 million in Series C funding to advance its radiopharmaceutical pipeline for cancer …

jacobsmgt.com

$175
OFF

Alpha-9 Oncology | Radiopharmaceuticals | Cancer Therapy

4 weeks from now

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals. BOSTON, Mass. and VANCOUVER, British …

a9oncology.com

$175
OFF

Alpha-9 Oncology Secures $175M In Oversubscribed Series C …

4 weeks from now

Nov 1, 2024  · Alpha-9 Oncology Inc., a clinical stage company focused on developing radiopharmaceuticals to enhance cancer treatment, has announced the successful closing of …

patsnap.com

$175
OFF

Alpha-9 Oncology Raises $175 Million In Series C | Citybiz

4 weeks from now

Oct 23, 2024  · Alpha-9 Oncology Inc., a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an …

citybiz.co

$175
OFF

Alpha-9 Oncology Secures $175 Million In Oversubscribed Series C …

4 weeks from now

Oct 24, 2024  · Alpha-9 Oncology Inc, a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, announced an …

readmagazine.com

$175
OFF

Alpha-9 Oncology Raises $175M Series C | Citybiz

4 weeks from now

Oct 24, 2024  · Alpha-9 Oncology Inc., a Boston, MA- and Vancouver, Canada-based clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of …

citybiz.co

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

BOSTON and VANCOUVER, BC, October 23, 2024-- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve …

vcaonline.com

$175
OFF

Radiopharma Biotech Alpha-9 Oncology Closes $175M Series C …

4 weeks from now

Oct 23, 2024  · Another private radiopharmaceutical biotech has raised big money. Alpha-9 Oncology revealed on Wednesday that it’s put together a $175 million Series C, aiming to fund …

endpts.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully …

epicos.com

$175
OFF

Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed …

4 weeks from now

Oct 24, 2024  · BOSTON, MA & VANCOUVER, BC – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve …

lifesciencesbc.ca

FAQs about Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed … Coupon?

Why did alpha-9 announce a $175 million Series C financing?

BOSTON and VANCOUVER, BC, Oct. 23, 2024 /PRNewswire/ -- Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

What is alpha-9 oncology doing with $175m in Series C funding?

The company will use the funds to advance its pipeline of cancer-targeting preclinical candidates to the “clinic-ready” stage. Alpha-9 Oncology has raised $175m in a Series C funding round to advance its pipeline of radiopharmaceuticals. Credit: eamesBot via Shutterstock. ...

Who is alpha-9 oncology?

BOSTON, Mass. and VANCOUVER, British Columbia, October 23, 2024 – Alpha-9 Oncology Inc. (Alpha-9 or the Company), a clinical stage company developing radiopharmaceuticals to meaningfully improve the treatment of people living with cancer, today announced an oversubscribed $175 million Series C financing to support the progression of its pipeline. ...

Why should you invest in a series C of alpha-9?

Furthermore, the Series C will fund expanded R&D capabilities and continued investment in CMC and supply chain. “Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. ...

Is alpha-9 a good radiopharmaceutical company?

“Over the last few years, Alpha-9 has built a leading radiopharmaceutical company with a deep pipeline and robust infrastructure,” said Alpha-9 CEO, David Hirsch, MD, PhD. “The Series C is an exciting, significant milestone for us and will greatly accelerate our growth. ...

What is alpha-9 pharmacology?

Alpha-9 is advancing a robust pipeline of novel radiopharmaceuticals with a systematic approach to molecule design that offers broad potential for expansion into several validated oncology targets. For more information, please visit www.a9oncology.com. About Lightspeed Venture Partners ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension